Global Contract Pharmaceutical Manufacturing Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Contract Pharmaceutical Manufacturing market report explains the definition, types, applications, major countries, and major players of the Contract Pharmaceutical Manufacturing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Aenova

    • Catalent

    • Lonza

    • Famar

    • Recipharm

    • Boehringer Ingelheim

    • Nipro Corp

    • DPx

    • AbbVie

    • Dishman

    • Vetter

    • Aesica

    • Piramal Healthcare

    • DPT Laboratories

    • Sopharma

    • Fareva Holding

    • NextPharma

    • Jubilant

    By Type:

    • API

    • FDF

    By End-User:

    • Specialty/Midsize

    • Generics

    • Big Pharma

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Contract Pharmaceutical Manufacturing Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Contract Pharmaceutical Manufacturing Outlook to 2028- Original Forecasts

    • 2.2 Contract Pharmaceutical Manufacturing Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Contract Pharmaceutical Manufacturing Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Contract Pharmaceutical Manufacturing Market- Recent Developments

    • 6.1 Contract Pharmaceutical Manufacturing Market News and Developments

    • 6.2 Contract Pharmaceutical Manufacturing Market Deals Landscape

    7 Contract Pharmaceutical Manufacturing Raw Materials and Cost Structure Analysis

    • 7.1 Contract Pharmaceutical Manufacturing Key Raw Materials

    • 7.2 Contract Pharmaceutical Manufacturing Price Trend of Key Raw Materials

    • 7.3 Contract Pharmaceutical Manufacturing Key Suppliers of Raw Materials

    • 7.4 Contract Pharmaceutical Manufacturing Market Concentration Rate of Raw Materials

    • 7.5 Contract Pharmaceutical Manufacturing Cost Structure Analysis

      • 7.5.1 Contract Pharmaceutical Manufacturing Raw Materials Analysis

      • 7.5.2 Contract Pharmaceutical Manufacturing Labor Cost Analysis

      • 7.5.3 Contract Pharmaceutical Manufacturing Manufacturing Expenses Analysis

    8 Global Contract Pharmaceutical Manufacturing Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Contract Pharmaceutical Manufacturing Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Contract Pharmaceutical Manufacturing Export by Region (Top 10 Countries) (2017-2028)

    9 Global Contract Pharmaceutical Manufacturing Market Outlook by Types and Applications to 2022

    • 9.1 Global Contract Pharmaceutical Manufacturing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global API Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global FDF Consumption and Growth Rate (2017-2022)

    • 9.2 Global Contract Pharmaceutical Manufacturing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Specialty/Midsize Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Generics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Big Pharma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Contract Pharmaceutical Manufacturing Market Analysis and Outlook till 2022

    • 10.1 Global Contract Pharmaceutical Manufacturing Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.2.2 Canada Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.2.3 Mexico Contract Pharmaceutical Manufacturing Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.2 UK Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.3 Spain Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.4 Belgium Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.5 France Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.6 Italy Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.7 Denmark Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.8 Finland Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.9 Norway Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.10 Sweden Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.11 Poland Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.12 Russia Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.3.13 Turkey Contract Pharmaceutical Manufacturing Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.2 Japan Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.3 India Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.4 South Korea Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.5 Pakistan Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.6 Bangladesh Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.7 Indonesia Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.8 Thailand Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.9 Singapore Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.10 Malaysia Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.11 Philippines Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.4.12 Vietnam Contract Pharmaceutical Manufacturing Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.5.2 Colombia Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.5.3 Chile Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.5.4 Argentina Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.5.5 Venezuela Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.5.6 Peru Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.5.7 Puerto Rico Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.5.8 Ecuador Contract Pharmaceutical Manufacturing Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.6.2 Kuwait Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.6.3 Oman Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.6.4 Qatar Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Contract Pharmaceutical Manufacturing Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.7.2 South Africa Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.7.3 Egypt Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.7.4 Algeria Contract Pharmaceutical Manufacturing Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Contract Pharmaceutical Manufacturing Consumption (2017-2022)

      • 10.8.2 New Zealand Contract Pharmaceutical Manufacturing Consumption (2017-2022)

    11 Global Contract Pharmaceutical Manufacturing Competitive Analysis

    • 11.1 Aenova

      • 11.1.1 Aenova Company Details

      • 11.1.2 Aenova Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Aenova Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.1.4 Aenova Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Catalent

      • 11.2.1 Catalent Company Details

      • 11.2.2 Catalent Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Catalent Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.2.4 Catalent Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Lonza

      • 11.3.1 Lonza Company Details

      • 11.3.2 Lonza Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Lonza Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.3.4 Lonza Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Famar

      • 11.4.1 Famar Company Details

      • 11.4.2 Famar Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Famar Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.4.4 Famar Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Recipharm

      • 11.5.1 Recipharm Company Details

      • 11.5.2 Recipharm Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Recipharm Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.5.4 Recipharm Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Boehringer Ingelheim

      • 11.6.1 Boehringer Ingelheim Company Details

      • 11.6.2 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.6.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Nipro Corp

      • 11.7.1 Nipro Corp Company Details

      • 11.7.2 Nipro Corp Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Nipro Corp Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.7.4 Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 DPx

      • 11.8.1 DPx Company Details

      • 11.8.2 DPx Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 DPx Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.8.4 DPx Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 AbbVie

      • 11.9.1 AbbVie Company Details

      • 11.9.2 AbbVie Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 AbbVie Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.9.4 AbbVie Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Dishman

      • 11.10.1 Dishman Company Details

      • 11.10.2 Dishman Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Dishman Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.10.4 Dishman Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Vetter

      • 11.11.1 Vetter Company Details

      • 11.11.2 Vetter Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Vetter Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.11.4 Vetter Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Aesica

      • 11.12.1 Aesica Company Details

      • 11.12.2 Aesica Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Aesica Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.12.4 Aesica Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Piramal Healthcare

      • 11.13.1 Piramal Healthcare Company Details

      • 11.13.2 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.13.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 DPT Laboratories

      • 11.14.1 DPT Laboratories Company Details

      • 11.14.2 DPT Laboratories Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Sopharma

      • 11.15.1 Sopharma Company Details

      • 11.15.2 Sopharma Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Sopharma Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.15.4 Sopharma Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Fareva Holding

      • 11.16.1 Fareva Holding Company Details

      • 11.16.2 Fareva Holding Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Fareva Holding Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.16.4 Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 NextPharma

      • 11.17.1 NextPharma Company Details

      • 11.17.2 NextPharma Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 NextPharma Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.17.4 NextPharma Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Jubilant

      • 11.18.1 Jubilant Company Details

      • 11.18.2 Jubilant Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Jubilant Contract Pharmaceutical Manufacturing Main Business and Markets Served

      • 11.18.4 Jubilant Contract Pharmaceutical Manufacturing Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    12 Global Contract Pharmaceutical Manufacturing Market Outlook by Types and Applications to 2028

    • 12.1 Global Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global API Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global FDF Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Specialty/Midsize Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Generics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Big Pharma Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Contract Pharmaceutical Manufacturing Market Analysis and Outlook to 2028

    • 13.1 Global Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.2.2 Canada Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.2 UK Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.3 Spain Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.5 France Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.6 Italy Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.8 Finland Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.9 Norway Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.11 Poland Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.12 Russia Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.2 Japan Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.3 India Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.5.3 Chile Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.5.6 Peru Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.6.3 Oman Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Contract Pharmaceutical Manufacturing Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Contract Pharmaceutical Manufacturing

    • Figure of Contract Pharmaceutical Manufacturing Picture

    • Table Global Contract Pharmaceutical Manufacturing Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Contract Pharmaceutical Manufacturing Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global API Consumption and Growth Rate (2017-2022)

    • Figure Global FDF Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty/Midsize Consumption and Growth Rate (2017-2022)

    • Figure Global Generics Consumption and Growth Rate (2017-2022)

    • Figure Global Big Pharma Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Contract Pharmaceutical Manufacturing Consumption by Country (2017-2022)

    • Table North America Contract Pharmaceutical Manufacturing Consumption by Country (2017-2022)

    • Figure United States Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Canada Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Mexico Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Table Europe Contract Pharmaceutical Manufacturing Consumption by Country (2017-2022)

    • Figure Germany Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure UK Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Spain Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Belgium Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure France Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Italy Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Denmark Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Finland Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Norway Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Sweden Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Poland Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Russia Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Turkey Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Table APAC Contract Pharmaceutical Manufacturing Consumption by Country (2017-2022)

    • Figure China Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Japan Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure India Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Thailand Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Singapore Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Philippines Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Table South America Contract Pharmaceutical Manufacturing Consumption by Country (2017-2022)

    • Figure Brazil Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Colombia Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Chile Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Argentina Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Peru Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Table GCC Contract Pharmaceutical Manufacturing Consumption by Country (2017-2022)

    • Figure Bahrain Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Oman Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Qatar Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Table Africa Contract Pharmaceutical Manufacturing Consumption by Country (2017-2022)

    • Figure Nigeria Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure South Africa Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Egypt Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Algeria Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Table Oceania Contract Pharmaceutical Manufacturing Consumption by Country (2017-2022)

    • Figure Australia Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Contract Pharmaceutical Manufacturing Consumption and Growth Rate (2017-2022)

    • Table Aenova Company Details

    • Table Aenova Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aenova Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Aenova Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Catalent Company Details

    • Table Catalent Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Catalent Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Catalent Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Lonza Company Details

    • Table Lonza Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonza Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Lonza Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Famar Company Details

    • Table Famar Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Famar Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Famar Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Recipharm Company Details

    • Table Recipharm Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Recipharm Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Recipharm Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Nipro Corp Company Details

    • Table Nipro Corp Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nipro Corp Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio

    • Table DPx Company Details

    • Table DPx Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table DPx Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table DPx Contract Pharmaceutical Manufacturing Product Portfolio

    • Table AbbVie Company Details

    • Table AbbVie Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table AbbVie Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Dishman Company Details

    • Table Dishman Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dishman Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Dishman Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Vetter Company Details

    • Table Vetter Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vetter Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Vetter Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Aesica Company Details

    • Table Aesica Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aesica Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Aesica Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Piramal Healthcare Company Details

    • Table Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Piramal Healthcare Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio

    • Table DPT Laboratories Company Details

    • Table DPT Laboratories Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table DPT Laboratories Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Sopharma Company Details

    • Table Sopharma Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sopharma Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Sopharma Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Fareva Holding Company Details

    • Table Fareva Holding Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fareva Holding Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio

    • Table NextPharma Company Details

    • Table NextPharma Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table NextPharma Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table NextPharma Contract Pharmaceutical Manufacturing Product Portfolio

    • Table Jubilant Company Details

    • Table Jubilant Contract Pharmaceutical Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant Contract Pharmaceutical Manufacturing Main Business and Markets Served

    • Table Jubilant Contract Pharmaceutical Manufacturing Product Portfolio

    • Figure Global API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global FDF Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty/Midsize Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Big Pharma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contract Pharmaceutical Manufacturing Consumption Forecast by Country (2022-2028)

    • Table North America Contract Pharmaceutical Manufacturing Consumption Forecast by Country (2022-2028)

    • Figure United States Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Contract Pharmaceutical Manufacturing Consumption Forecast by Country (2022-2028)

    • Figure Germany Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Contract Pharmaceutical Manufacturing Consumption Forecast by Country (2022-2028)

    • Figure China Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Contract Pharmaceutical Manufacturing Consumption Forecast by Country (2022-2028)

    • Figure Brazil Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Contract Pharmaceutical Manufacturing Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Contract Pharmaceutical Manufacturing Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Contract Pharmaceutical Manufacturing Consumption Forecast by Country (2022-2028)

    • Figure Australia Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Contract Pharmaceutical Manufacturing Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.